15th JBF Symposium

Program Summary (Tentative)

​
THE 15TH JBF SYMPOSIUM PROGRAM (as of 8th Sep. 2023)
Date : Mon, 5th Feb. – Wed, 7th Feb. 2024
Venue：Miyako Messe Kyoto International Exhibition Hall (Kyoto) and Virtual meeting
Language translation script (Japanese / English) will be projected at the main venue.
 
Day 1: Monday, 5th Feb.
12:00-12:20         Opening Remarks (Main venue / Japanese)
  • Executive Committee Chair of the 15th JBF Symposium
  • JBF Representative
12:20-13:20       Recent trend and concerns on the document-based inspection in the Japanese new drug approval
 (Main venue / Japanese)
A reform regarding the methods for confirming compliance with the reliability criteria of NDA application materials. Potential impact on the practical aspects related to bioanalysis will be discussed.
Planned Presentations:
  • Revision of Reliability Criteria Checklist
  • Impact on Bioanalytical Practices
13:20-14:20       Poster / Booth Viewing (Poster venue, Booth)
To facilitate efficient discussions and interactions, viewing time will be provided on the first day.
14:20-16:20         Method Development and Standardization for qPCR (Main venue / Japanese / English)
Latest efforts in technical considerations, implementation examples, and standardization of qPCR will be provided.
Planned Presentations:
  • Outcome from qPCR Standardization Research Group
  • Best practices discussed in the JBF discussion group
  • Examples of qPCR and ddPCR Implementation
  • Implementation under GLP and Reporting Standards
16:30-17:30         Basic lecture (Main venue / Japanese)
Basic lecture targeting early carrier scientists will be provided.
  • Basic Lecture of LC/MS
  • Basic Lecture on Analytical Method Development for ADA in LBA
Day 2: Tuesday, 6th Feb.

9:00-10:50         Challenges in Setting Cut-Off Values for Anti-Drug Antibody Assays (Main venue / English)
There are complex challenges in setting cut-off values for anti-drug antibody assays. Presenters are invited from overseas to facilitate detailed discussions on this topic in Japan.
Planned Presentations:

  • Practical Advice & Insights on Immunogenicity Cut Points
  • Clinical Relevance of Determining Appropriate Cut Points
11:00-12:00       Poster Presentation (Poster)
12:15-13:15       Luncheon (Main venue, Sub venue, Luncheon room 1, Luncheon room 2 / Basically Japanese, English speaker can present in English)
13:40-15:10
Program A: Next-generation AI Utilization in Day-to-day Operations (Main venue / Japanese)
Due to advancements in AI, work is on the brink of a transformation. Future potential applications will be provided to create an opportunity to initiate diverse discussions.
Planned Presentations:
  • Significance of Generative AI and Its Potential in Educational Training
  • Literature Search and Document Creation with AI
  • Potential of Motion Analysis AI for Technical Knowledge Transfer
Program B: Career visions of bioanalysts (Sub venue / Japanese)
Career development has become a significant challenge for each individual. Current expectation on skillset will be provided to gain insights into how to proceed in the future.
Planned Presentations:
  • Career Development for Bioanalysts
  • Essentials for a Career in Bioanalysis
  • What has been Beneficial in the Course of Evolving Professional Experiences
  • Panel Discussion
15:20-16:20
Program A: Data Integrity (Main venue / Japanese)
Updates in considerations in implementing computerized systems are provided from experts from Japan Society of Quality Assurance.
Planned Presentations:
  • Considerations in implementing computerized systems
Program B: t-DG (temporal Discussion Group) (In all venue in small groups / Japanese)
Participants will be divided into small groups to engage in discussions on topics they have selected. Additional registration is required to attend this session.
16:30-17:30       ICH M10 Implementation Insights: Experiences and Lessons Learned from Bioanalytics Communities (1) (Main venue / English or Japanese)
In a situation where the ICH M10 guideline is in the implementation phase in Japan and already implemented in other regions, review of discussions undertaken is provided by speakers from Japan, the US, and Europe.
  • Presentations: TBD (In the evening session, one Japanese and one Europe-based presenter will be assigned.)

18:00-19:30         Banquet

Day 3: Wednesday, 7th Feb.

ICH M10 Implementation Insights: Experiences and Lessons Learned from Bioanalytics Communities (2) (Main venue / English or Japanese)

  • Presentations: TBD (In the morning session, one Japanese and one US-based presenter will be assigned.)
10:10-11:10         Poster Presentation (Poster)
11:25-12:25         Luncheon (Main venue, Sub venue, Luncheon room 1, Luncheon room 2 / Basically Japanese, English speaker can present in English)
12:50-14:50       Issues and solutions for LC/MS analysis of peptides (Main venue / Japanese)
Medium-sized peptides have recently gained attention as a promising drug modality. Technical considerations during the LC-MS/MS method development, strategies for overcoming challenges, and introduce the latest technologies will be presented.
Planned Presentations: Details are to be determined;
  • Standardization of Advanced Peptide Drug Bioanalysis
  • TBD (Presentations of basic research to overcome technical challenges from three hardware vendors)
14:50-15:10         Closing Remarks
  • Executive Committee Chair of the 16th JBF Symposium

 [Note]
This program is provisional and subject to change in the future.